WHAT IS FEMTOUCH?
FemTouch is a state-of-the-art, minimally invasive outpatient procedure developed by Lumenis, the leading company for aesthetic medical laser devices, in collaboration with leading gynecologists. FemTouch treatments can alleviate vaginal dryness, laxity, discomfort or pain during intercourse, as well as urinary incontinence issues.
WHO NEEDS FEMTOUCH?
Approximately 24 percent of women between the ages of 18 and 44 experience urinary incontinence. Nearly 50 percent of postmenopausal women suffer from stress urinary incontinence, or the unintentional loss of urine caused by physical movement such as coughing, sneezing, laughing, running, or heavy lifting.
FemTouch is suitable for nearly all women, including those:
• in peri-menopause, menopause, and post-menopause
• with symptoms caused by surgery, cancer medication, or those who are unable to use hormone-based treatment
• who haven’t responded to topical estrogen or find administration unpleasant
• with painful perineal scarring post-birth
• with recurrent yeast or bladder infections
• who experience pain, vaginal discomfort, or bleeding during intercourse
• with lost elasticity, mild prolapse, or light bladder leakage
WHAT CAN WE DO ABOUT IT?
For the first time in human history, doctors have an additional method other than surgery that can safely treat vaginal atrophy. FemTouch is a minimally invasive, non-surgical, no downtime procedure that treats postmenopausal vaginal atrophy and all of the unpleasant side effects, safely and effectively.
HOW DOES FEMTOUCH WORK?
FemTouch utilizes CO2 energy levels in a fractional pattern to remodel the connective tissue and stimulate new collagen growth. FemTouch treats vaginal health conditions by promoting remodeling of the vaginal mucosa and revitalizing the tissue at a full 360-degrees. The laser treatments stimulate collagen and elastin to create new, healthy tissue and promote blood flow.
Women can ultimately gain restoration of the vaginal canal to a premenopausal-like stage with FemTouch treatments and can experience fewer adverse symptoms that are accompanied by vaginal atrophy and incontinence.
WHAT RESULTS CAN I EXPECT?
The measurable results include a restoration of the vaginal epithelium thickness and fibroblasts synthesized into new collagen. Patients have experienced a reversal of their bothersome symptoms including painful intercourse, tissue tearing, and loss of sexual pleasure.
